Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of Metastatic Prostate Cancer Subjects Receiving Docetaxel Therapy for Evaluation of Docetaxel Plasma Levels Using the MyDocetaxel Assay

NCT02376296 is registered in ClinicalTrials.gov with Saladax Biomedical, Inc. as lead sponsor.

NCT NCT02376296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02376296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of Metastatic Prostate Cancer Subjects Receiving Docetaxel Therapy for Evaluation of Docetaxel Plasma Levels Using the MyDocetaxel Assay
Lead sponsor
Saladax Biomedical, Inc.
Phase
Observational
Overall status
Completed
Start date
February 28, 2015
Completion date
February 10, 2018
Enrollment
35 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer